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Executive Summary
Reaching our nation’s HIV prevention goals is essential for protecting and improving the health of all people who 
are at risk for or living with HIV infection. The Centers for 
Disease Control and Prevention (CDC) Division of HIV/
AIDS Prevention (DHAP) Strategic Plan supports the four 
goals of the National HIV/AIDS Strategy for the United States 
(NHAS) related to: reducing new HIV infections; increasing 
access to care and improving health outcomes for people 
living with HIV; reducing HIV-related disparities and health 
inequities; and achieving a more coordinated national response 
to the HIV epidemic.
In 2013, CDC published the first National HIV Prevention 
Progress Report (NPR) to describe progress toward achieving 
the goals and objectives of the DHAP Strategic Plan for 2011-
2015 (aligned with the NHAS goals for 2015). The report 
used data from CDC HIV surveillance systems to report on 
21 key indicators. The first NPR served as a baseline report. 
This second NPR describes progress toward 2015 goals for 
15 indicators adding additional data available for 2010-2014. 
Years of available data vary by indicator. The report highlights 
differences by age, gender, race/ethnicity, and HIV transmission risk—recognizing that progress among those 
disproportionately affected by HIV is important for achieving national goals and improving health equity.
In the NPR, progress toward achieving 2015 goals is evaluated against annual targets. These targets are based on the 
assumption that improvement will accelerate over time as more of the benefits of a high-impact approach to HIV 
prevention are realized. Achieving all of our nation’s HIV prevention goals will not be easy. It is dependent upon 
progress at the local level and in groups that are disproportionately affected by HIV.
Results available midway through the 5-year DHAP Strategic Plan period (2011-2015) 
show areas where we are making good progress and areas where we need to do better.
• For 9 of 15 indicators (60%), annual targets were met. HIV testing efforts have succeeded in increasing 
the percentage of people living with HIV who are aware of their infection. More persons with diagnosed HIV 
are being linked to HIV medical care and viral suppression has improved among persons in HIV medical care, 
including among gay, bisexual and other men who have sex with men (MSM) and blacks/African Americans. 
These results are encouraging and show progress along the HIV care continuum that will lead to better 
health for persons living with HIV and fewer new HIV infections.
• For 3 of 15 indicators (20%), annual targets were not met but there was movement toward the 
target. More work is needed to increase progress on linkage to HIV medical care among groups that are 
disproportionately affected by HIV especially blacks/African Americans and Hispanics/Latinos.
• For 3 of 15 indicators (20%), annual targets were not met. There was no change or movement away 
from the target. There is an urgent need to improve the effectiveness of HIV prevention efforts for MSM, 
people who inject drugs, and groups disproportionately affected by HIV. Increasing viral suppression 
among Hispanics/Latinos will require strategies to ensure retention in HIV medical care, early and effective 
treatment, and adherence to treatment.
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The updated NHAS uses HIV diagnoses 
rather than estimates of new infections 
as the indicator for monitoring progress 
toward reducing new infections. Incidence 
estimates are not published annually and 
estimation methods improve over time making 
it difficult to use estimated incidence as an 
indicator for measuring progress. HIV diagnosis 
data are published annually in a routine and 
standardized format, are available for all 
states, and can approximate incidence when 
HIV testing rates remain stable. Given these 
advantages, HIV diagnoses will be used as an 
indicator in future NPRs. CDC will periodically 
publish incidence data, but HIV incidence and 
transmission indicators have been retired. 
Starting in 2016, the NPR will be revised to align with the updated NHAS for 2020 (released by the White House in 
July 2015) and the new DHAP Strategic Plan for 2016-2020. While some indicators will remain unchanged, some 
new ones will be added, others revised, and some retired. Key changes will include monitoring new HIV diagnoses 
rather than incidence; adding retention in HIV medical care and the death rate among persons with diagnosed HIV 
infection; and revising linkage to HIV medical care to within one month of diagnosis rather than 3 months. These 









Prevent New HIV Infections
Reduce new HIV infections by 25% Indicator Retired*
Increase knowledge of HIV-positive status to 90% 90.0% 2012 82.7% 87.2%
Reduce late stage HIV diagnosis by 25% 18.9% 2013 22.7% 23.6%
Reduce the perinatal HIV transmission rate by 25% 4.8 2012 6.1 4.6
Reduce sexual risk behavior among MSM by 25% 10.3% 2014 11.3% 15.7%
Reduce sexual or injection risk behavior among PWID by 25% 54.8% 2012 69.4% 76.9%
Increase Access to HIV Care and Improve Health Outcomes for People Living with HIV
Reduce the HIV transmission rate by 30% Indicator Retired*
Increase linkage to HIV medical care to 85% 85.0% 2013 73.0% 82.1%
Increase viral suppression among persons in HIV medical care by 10% 78.8% 2013 74.5% 80.1%
Reduce sexual risk behavior among persons in HIV medical care by 33% 8.6% 2013 11.2% 10.7%
Reduce HIV-Related Disparities and Health Inequities
Reduce new HIV infections among groups at increased risk by at least 25%
— MSM, PWID, Blacks/African Americans, Hispanics/Latinos Indicators Retired*
Increase linkage to HIV medical care among all racial/ethnicity groups to 85% or greater
— Blacks/African Americans 85.0% 2013 80.1% 79.0%
— Hispanics/Latinos 85.0% 2013 83.9% 83.0%
— Whites 85.0% 2013 84.1% 86.2%
— Persons of other races/ethnicities 85.0% 2013 81.4% 83.6%
Increase viral suppression among specific groups by at least 20%
— MSM with diagnosed HIV 49.8% 2012 43.2% 45.5%
— Blacks/African Americans with diagnosed HIV 40.9% 2012 35.5% 39.0%
— Hispanics/Latinos with diagnosed HIV 42.5% 2012 36.8% 35.6%
Met or exceeded        
current annual target
Not met—moved toward annual 
target in most recent data year
Not met—no change or moved away from 
annual target in most recent data year
Annual Targets and Results represent the most currently available data. See Indicator Summaries and Technical Notes for additional 
information.
* Incidence estimates are not published annually and estimation methods improve over time making it difficult to use estimated incidence as
an indicator for measuring progress. HIV diagnosis data are published annually in a routine and standardized format, are available for all states,
and can approximate incidence when HIV testing rates remain stable. Given these advantages, HIV diagnoses will be used as an indicator in the
NHAS updated to 2020 and in future NPRs. CDC will periodically publish incidence data, but HIV incidence and transmission indicators have
been retired.
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Introduction
Reaching our nation’s HIV prevention goals is essential for protecting and improving the health of all people who are 
at risk for or living with HIV infection. The National HIV/AIDS Strategy for the United States (NHAS), published 
in 2010, represents the nation’s first comprehensive plan for addressing HIV. In July 2015, the NHAS was updated to 
reflect outcomes expected to be achieved by 2020. However, the four goals of the NHAS remain unchanged:
• reducing new HIV infections;
• increasing access to care and improving health outcomes for people living with HIV;
• reducing HIV-related disparities and health inequities, and;
• achieving a more coordinated national response to the HIV epidemic.
The Centers for Disease Control and Prevention (CDC) Division of HIV/AIDS Prevention (DHAP) Strategic Plan 
supports the goals of the NHAS and provides a road map for CDC’s response to domestic HIV. CDC’s response 
includes supporting prevention programs, raising HIV awareness, tracking trends in HIV, and supporting prevention 
research. These activities are guided by CDC’s high-impact prevention approach for aligning the most cost-effective 
and scalable interventions geographically and demographically with the burden of HIV. The approach is designed to 
maximize the impact of federal prevention dollars and further our collective progress toward achieving the goals of 
the NHAS. CDC works with partners in other federal, state, and local agencies to support proven strategies that can 
reduce the risk of acquiring or transmitting HIV and improve the health of people living with HIV.
In 2013, CDC published the first National HIV Prevention Progress Report (NPR) to describe progress toward 
achieving the goals and objectives of the DHAP Strategic Plan for 2011-2015 (aligned with the NHAS goals for 
2015). The report used data from CDC HIV surveillance systems to report on 21 key indicators that address the goals 
of the NHAS. The first NPR served as a baseline report and described indicator trends before 2011; where data were 
available, results were provided for the first year of implementation of the DHAP Strategic Plan.
This second NPR describes progress toward 2015 goals for 15 indicators adding additional data available for 
2010-2014. Six indicators that use HIV incidence data have been retired (see box). The years for which data are 
available vary by indicator. The report highlights differences by age, gender, race/ethnicity, and HIV transmission 
risk—recognizing that progress among those disproportionately affected by HIV is important for achieving national 
goals and improving health equity.
The updated NHAS uses HIV diagnoses rather than estimated new infections as the 
indicator for monitoring progress toward reducing new infections.
Beginning in 2016, new HIV diagnoses will replace estimated new HIV infections as the indicator for 
monitoring progress toward reducing new infections. Although HIV incidence estimates were used 
previously by the NHAS to measure reductions in new infections, incidence estimates are not published 
annually and therefore are not available to monitor progress on a yearly basis. In addition, the methodology 
used to estimate the number of new infections has changed, and likely will continue to improve over time 
due to changes in HIV testing technology and refined incidence estimation methods. These changes make 
it difficult to use estimated incidence as an indicator. HIV diagnosis data are published in a routine and 
standardized format, are available for all states, and can approximate incidence when HIV testing rates 
remain stable. Given these advantages, HIV diagnoses will be used as an indicator in the updated NHAS and 
in the DHAP Strategic Plan for 2016-2020 (expected to be released in early 2016). CDC will publish incidence 
data periodically, but indicators that use HIV incidence data have been retired.
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Measuring Progress
The fifteen indicators in this report provide an objective way to assess progress toward achieving key HIV 
prevention goals. They provide feedback that guides CDC planning and program improvement activities. The data 
for these indicators come from three CDC HIV surveillance systems (see box). Accurate and timely reporting of 
indicator data from these systems remains a priority for CDC. In this NPR, updates to previously published results 
are presented where available for indicators based on data from the National HIV Surveillance System (NHSS). The 
updated results include more complete data and less data duplication.
This report evaluates progress by comparing results with annual targets. Targets are based on the assumption that 
change will occur over time and will accelerate with each passing year. They take into account time needed for program 
planning and start-up activities, and for effects of programmatic changes to be reflected in the data. For each indicator, 
a baseline year was identified as the starting point for setting annual targets. The following assumptions were used to 
measure annual progress toward 2015 goals: 5% of the total change would occur by 2011, 20% by 2012, 40% by 
2013, 70% by 2014, and 100% by 2015. In this NPR, annual targets are revised for indicators with updated baseline 
year data (Perinatal HIV Transmission; HIV-Related Disparities and Health Inequities: Viral Suppression among 
Specific Groups with Diagnosed HIV). The Technical Notes provide additional information about the baseline, annual 
targets, and 2015 goal for each indicator, as well as the data sources and estimation methods used for measuring those 
indicators.
For each indicator, symbols are used to indicate where the current annual target was:
Met or exceeded        
current annual target
Not met—moved toward annual 
target in most recent data year
Not met—no change or moved away from 
annual target in most recent data year
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This report does not use statistical tests to assess changes over time, differences between groups, or differences between 
the result and the target. Rather, it compares the current annual target and result to assess whether the target has been 
met. Additionally, it highlights subgroups for which the 2015 goal has already been met. Statistically significant change 
is not expected from each year to the next and may not always be necessary to achieve the 2015 goal. Additional data 
for some indicators are available in other publications and may include information about statistical significance.
CDC HIV Surveillance Systems: Data Sources for Indicators
National HIV Surveillance System. All 50 states, the District of Columbia, and 6 dependent areas report 
confirmed diagnoses of HIV and AIDS to CDC including demographic characteristics, transmission category, 
and initial immune status. For 2013 data, 28 jurisdictions had complete reporting to CDC of CD4 and HIV viral 
load test results for January through December 2013. 
Medical Monitoring Project. MMP uses a three-stage sampling approach that is designed to produce 
nationally representative information about adults receiving HIV medical care in the United States. Data are 
collected for samples of patients at outpatient HIV medical care facilities. Since 2009, 16 states, 6 cities, and 
Puerto Rico have been funded to participate.
National HIV Behavioral Surveillance. NHBS conducts behavioral surveillance in rotating three-year cycles 
among three populations at high risk for HIV infection—MSM, persons who inject drugs, and heterosexuals at 
increased risk for HIV infection. Data are collected in US cities with a high burden of AIDS. As of 2011, 20 cities 
have been funded to conduct NHBS.
2
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Federal Monitoring and Reporting Activities
Many of the indicators in this report are part of other federal performance monitoring and reporting activities. In the 
Indicator Summaries, the following symbols denote the activities for which each indicator is reported:
National HIV/AIDS Strategy—a comprehensive national plan with clear and measurable HIV 
prevention goals. The strategy has been updated to 2020. Future NPRs will be aligned with 
indicators in the updated strategy.
Government Performance and Results Act—holds federal agencies accountable for achieving 
results through goal setting and performance measurement. Results are reported with the 
President’s annual budget request.
Healthy People 2020—science-based national objectives for improving the health of all 
Americans and measuring the impact of prevention activities.
Department of Health and Human Services (HHS) Core HIV Indicators—seven core 
indicators for monitoring HHS-funded HIV prevention and care services.
Some indicators are also used in two key CDC monitoring reports. The State HIV Prevention 
Progress Report highlights state progress on key indicators that address the goals of the NHAS 
and the DHAP Strategic Plan and for which state level data are available. Prevention Status 
Reports highlight for each of the 50 states and the District of Columbia the status of public 
health policies and practices that are designed to prevent or reduce 10 important public health 
problems, including HIV infection.
Summary of Results
Results available midway through the 5-year DHAP Strategic Plan period (2011-2015) show areas where we are mak-
ing good progress and areas where we need to do better.
For 9 of 15 indicators (60%), annual targets were met.
• HIV testing efforts have succeeded in increasing the percentage of people living with HIV who are aware of their 
infection.
• HIV testing of pregnant women and effective HIV treatment for women living with the virus have contributed 
to a reduction in the rate of perinatally acquired HIV infection.
• More people are being linked to HIV medical care within 3 months after diagnosis, especially whites and persons 
of other races/ethnicities. Progress has been made increasing viral suppression among persons in  HIV medical 
care and among MSM and blacks/African Americans with diagnosed HIV.
• These results are encouraging and show progress along the HIV care continuum that will lead to better health for 
persons living with HIV and fewer new HIV infections.
For 3 of 15 indicators (20%), annual targets were not met but there was movement toward the target.
• More work is needed to increase progress on linkage to HIV medical care among groups that are 
disproportionately affected by HIV especially blacks/African Americans and Hispanics/Latinos.
For 3 of 15 indicators (20%), annual targets were not met. There was no change or movement away from the target.
• There is an urgent need to improve the effectiveness of HIV prevention efforts for MSM, people who inject 
drugs, and other groups disproportionately affected by HIV.
• Increasing viral suppression among Hispanics/Latinos will require strategies to ensure retention in HIV medical 
care, early and effective treatment, and adherence to treatment.
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Looking Forward
Achieving our nation’s HIV prevention goals will result in fewer new HIV infections, increased access to care and 
improved health outcomes for people living with HIV, and reduced HIV-related disparities and health inequities. 
However, the road to reaching our goals will not be easy. Aided by CDC funding, health departments are in the 
process of implementing high-impact prevention activities but it will take time to fully realize the impact of cost-
effective and scalable prevention strategies. While effective HIV treatment has made it possible for more people with 
HIV to live longer, healthier lives, it also means there are more people living with HIV in need of HIV medical care 
and prevention services.
More than ever, monitoring HIV prevention indicators and actively using indicator data for program refinement 
and improvement are essential. The NPR is a tool for supporting and informing that process. It raises awareness 
about our nation’s progress toward 2015 goals. It highlights areas where we are doing well and areas where more 
improvement is needed. The NPR complements the CDC State HIV Prevention Progress Report (SPR), which 
monitors the progress of each of the 50 states and the District of Columbia related to key HIV prevention and care 
indicators for which data are available at the state level.
Starting in 2016, the NPR will be revised to align with the updated NHAS for 2020 (see box) and the new DHAP 
Strategic Plan for 2016-2020. While some indicators will remain unchanged, some new ones will be added, others 
revised, and some retired.
One key change will be monitoring new HIV diagnoses rather than HIV incidence. Disparities in new diagnoses will 
be assessed using the rate of new diagnoses for specific groups—MSM; young black MSM; black females; and persons 
living in the Southern United States. Other important changes will include monitoring retention in HIV medical care 
and the death rate among persons living with diagnosed HIV infection; revising linkage to HIV medical care to within 
one month of diagnosis rather than 3 months; and assessing viral suppression among all persons with diagnosed HIV 
rather than among those in HIV medical care.
Future NPRs will focus on indicators in the new DHAP Strategic Plan for 2016-2020 
which will include the following updated NHAS indicators.
Indicator 1 Increase the percentage of people living with HIV who know their serostatus to at least 90%
Indicator 2 Reduce the number of new diagnoses by at least 25%
Indicator 3 Reduce the percentage of young gay and bisexual men who have engaged in HIV risk 
behaviors by at least 10%
Indicator 4 Increase the percentage of newly diagnosed persons linked to HIV medical care within one 
month of their HIV diagnosis to at least 85%
Indicator 5 Increase the percentage of persons with diagnosed HIV infection who are retained in HIV 
medical care to at least 90%
Indicator 6 Increase the percentage of persons with diagnosed HIV infection who are virally suppressed to 
at least 80%
Indicator 7 Reduce the percentage of persons in HIV medical care who are homeless to no more than 5%
Indicator 8 Reduce the death rate among persons with diagnosed HIV infection by at least 33%
Indicator 9 Reduce disparities in the rate of new diagnoses by at least 15% in the following groups: gay 
and bisexual men, young Black gay and bisexual men, Black females, and persons living in the 
Southern United States
Indicator 10 Increase the percentage of youth and persons who inject drugs with diagnosed HIV infection 
who are virally suppressed to at least 90%

Indicator Summaries
Increase Knowledge of HIV-Positive Status to 90%
Percentage of people living with HIV who know their HIV-positive status
80.9% 83.3%

















DHAP Strategic PlanBaseline: 2006
Results improved each year 
from 2007 to 2012. By 2012, 
7 of 8 people living with 
HIV had been diagnosed.
People living with HIV need to know their HIV status to receive medical care, stay healthy, and reduce their risk for 
transmitting the virus to others. HIV testing efforts have succeeded in 
increasing the number of persons who are aware of their infection. 
From 2007 to 2012, the percentage of people living with HIV who 
had been diagnosed (and who are assumed to know about their HIV 
infection) increased from 83.3% to 87.2%, with improvement reported 
each year1. The 2012 target (82.7%) was met; we are on track for 
meeting the 2015 goal (90.0%).
Among subgroups, diagnosis of HIV infection improved from 2007 to 2012 among young people aged 13-24 
years (30% increase) and among most transmission risk groups. The 2015 goal (90.0%) has been met for males and 
females with infection attributed to injection drug use; gay, bisexual and other men who have sex with men (MSM) 
with infection attributed to injection drug use; and persons aged 45 years and older. The percentage of people 
with undiagnosed HIV infection remains highest among those under 35 years of age, MSM, and heterosexual 
males and females.
Action Needed: As the number of people with undiagnosed HIV infection becomes smaller, making each new 
diagnosis will be harder, creating additional challenges for testing programs. However, increased health insurance 
coverage for HIV testing as a result of the Affordable Care Act may improve access. And HIV testing may increase 
if more providers adopt current CDC and US Preventive Services Task Force recommendations for routine HIV 
screening among adults and adolescents where prevalence of undiagnosed infections is ≥0.1% and for at least 
annual screening for persons likely to be at increased risk (e.g., MSM, persons who inject drugs).
Data Source: National HIV Surveillance System (NHSS). See Technical Notes for additional information.
1 This report includes 2006 baseline data reported previously and updated data for 2007-2012. Comparisons are made between 2007 and 2012, 
the years for which updated data are available.
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2006 2007 2008 2009 2010 2011 2012
Undiagnosed HIV infection Diagnosed HIV infection
Fewer people have undiagnosed 
HIV infection
The total number of people living with 
HIV (HIV prevalence) increased 9% from 
1,121,900 in 2007 to 1,218,400 in 2012. 
Even though HIV prevalence increased, 
the number of people with undiagnosed 
HIV infection decreased 17% from 
187,357 in 2007 to 156,300 in 2012. 
More than 1 million people living with 
HIV had been diagnosed as of 2012.
Knowledge of HIV-Positive Status 
by Transmission Risk
• The percentage of people living with diagnosed
HIV improved in most transmission risk groups
from 2007 to 2012. Among heterosexual males,
the percentage with diagnosed HIV increased
11% from 2007 to 2012.
• The 2015 goal (90.0%) was met for males and
females with infection attributed to injection
drug use, and for MSM with infection attributed
















Knowledge of HIV-Positive Status by Age
• From 2007 to 2012, the greatest increase in
diagnosis of HIV was among young people
aged 13-24 years (30%).
• Despite this improvement, young people aged
13-24 years living with HIV are least likely of
all age groups to know they are infected with
HIV. This may be because they may have been
infected more recently and have had less time
to be tested and have their infection diagnosed
compared to older adults.
• Diagnosis of HIV remained fairly stable among
persons aged 35-64 years. There was slight 
improvement among 25-34 year olds (5%) and 
persons aged 65 years and older (6%).

















National HIV Prevention Progress Report, 2015 8
Reduce Late Stage HIV Diagnosis by 25%
Percentage of people with a diagnosis of stage-3 HIV infection (AIDS) 
















Late HIV diagnoses are 
declining, but about 1 of 
4 people living with HIV 
receive a late diagnosis.
Diagnosis in the early stages of HIV infection improves the health and survival of people living with HIV and 
reduces HIV transmission. People with HIV infection diagnosed at an advanced stage of disease have most likely 
been infected for many years and represent missed opportunities to diagnose and treat the infection and to 
prevent transmission to others.
From 2010 to 2013, the percentage of people with HIV diagnosed at a late 
stage decreased 6%, from 25.2% to 23.6%. The 2013 target (22.7%) was not 
met, but there was movement toward the annual target. 
Groups with the highest percentage of persons with HIV diagnosed at a 
late stage include heterosexual males, males with infection attributed to 
injection drug use, and persons aged 35 years and older. Among race/
ethnicity groups, diagnosis at a late stage declined from 2010 to 2013 among Native Hawaiians and Other Pacific 
Islanders (15%), Hispanics/Latinos (9%), blacks/African Americans (6%), and whites (6%). By gender, diagnosis at a 
late stage declined 8% among males and remained stable among females. In 2013, the 2015 goal (18.9%) was met 
for gay, bisexual and other men who have sex with men with infection attributed to injection drug use (MSM-IDU) 
and persons under 35 years of age.
Action Needed: To achieve the 2015 goal, widespread implementation of routine HIV screening is necessary. The 
greatest improvement is needed among heterosexual men, men with infection attributed to injection drug use, 
and persons aged 35 years and older.
Data Source: National HIV Surveillance System (NHSS). See Technical Notes for additional information.
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Late-Stage HIV Diagnosis 
by Transmission Risk
• From 2010 to 2013, there was a 22% decrease
in late stage diagnosis among MSM with 
infection attributed to injection drug use 
(MSM-IDU).
• There was a 12% increase among females with
infection attributed to injection drug use and
a 7% decrease among MSM, during this time.
Late stage diagnosis remained stable among
other transmission risk groups.
















Late-Stage HIV Diagnosis by Age
• From 2010 to 2013, the percentage of people
with a late stage diagnosis was fairly stable
within all but two age groups. Late stage
diagnosis decreased 8% among 25-34 year olds,
and 6% among persons 45 years and older.
• The percentage of people with HIV diagnosed at
a late stage increases with age.
• The 2015 goal (18.9%) was met among young
people aged 13-24 years from 2010 to 2013.
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Reduce Perinatal HIV Transmission by 25%















2008 2009 2010 2011 2012 2013 2014 2015
Status
DHAP Strategic PlanBaseline: 2008
Annual Target
2015 Goal
Perinatal HIV transmission 
continues to decline, but 
rates remain high among 
black/African American 
women and their infants.
Perinatal HIV transmission from mother to child can occur during 
pregnancy, labor and delivery, or breastfeeding. The perinatal HIV 
transmission rate measures the number of infants with perinatally 
acquired HIV infection per 100,000 live births. HIV testing of pregnant 
woman, and effective HIV treatment for women living with the virus, have 
contributed to the decline in the number of infants who were perinatally 
infected with HIV.
In 2012, an estimated 181 infants acquired HIV perinatally, 
which is equivalent to 4.6 HIV cases per 100,000 live births. 
This reflects a 28% reduction in the rate of perinatally acquired 
HIV infection from 2008 to 2012. Much of this decrease 
occurred during 2008 through 2010. The 2012 target (6.1) was 
met. We are on track for meeting the 2015 goal (4.8).
From 2008 to 2012, perinatal HIV infection was consistently 
higher among black/African American infants than among 
Hispanic/Latino or white infants. The rate among black/
African American infants decreased 18% during this time. The 
2015 goal (4.8) has been met since 2008 among white and 
Hispanic/Latino infants.
Action Needed: Perinatal HIV transmission remains 
unacceptably high among blacks/African Americans. HIV 
testing and treatment of HIV infection needs to increase 
among black/African American women of reproductive age to 
reduce HIV transmission.














Data Source: National HIV Surveillance System (NHSS). See Technical Notes for additional information.
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Reduce Sexual Risk Behavior among MSM by 25%
Percentage of gay, bisexual and other men who have sex with men (MSM) who 
report condomless anal intercourse with a male sex partner of discordant or 














Among MSM, anal sex 
without a condom with a 
discordant or unknown HIV 
status partner increased 
from 2008 to 2014.
Having anal sex without using a condom is a risky behavior for HIV infection―especially if other highly effective 
risk reduction strategies such as pre-exposure prophylaxis (PrEP) and 
antiretroviral treatment of HIV infection are not used. It is important 
that gay, bisexual, and other men who have sex with men (MSM) lower 
their HIV risk by using one or more existing prevention strategies. This 
indicator measures condomless anal sex only. CDC also collects data on 
the use of other prevention strategies and is exploring how best to use 
these data in future reports.
Every three years, CDC collects data about sexual risk behaviors among 
MSM in selected cities. Comparing 2008 and 2014, the percentage of 
MSM who reported having condomless anal sex with a discordant or unknown HIV status partner during their 
last sexual encounter increased 15% from 13.7% to 15.7%. The 2014 target (11.3%) was not met and there was 
movement away from the target. This indicator will not be assessed in 2015 because data will not be available.
The percentage change in condomless anal sex from 2008 to 2014 varied across subgroups. By age, condomless 
sex increased 12% among MSM aged 18-24 years; 19% among those aged 30-39 years; 28% among those aged 
40-49 years; and 22% among those 50 years and older. Across race/ethnicity groups, condomless sex increased
for Asians/Native Hawaiians and Other Pacific Islanders (26%); whites (19%); blacks/African Americans (9%); and
Hispanics/Latinos (8%). In 2014, the 2015 goal (10.3%) was met for American Indian/Alaska Native MSM and Asian/
Native Hawaiian and Other Pacific Islander MSM. The 2015 goal was not met for any age group.
Action Needed: There is an urgent need to improve the effectiveness of HIV prevention efforts for all MSM, 
especially young, racial/ethnic minority MSM, and MSM living with HIV. These efforts should aim to increase 
the use of condoms and other highly effective risk reduction strategies like PrEP and antiretroviral treatment for 
persons living with HIV. Too few gay and bisexual men in the United States are using these strategies consistently. 
Increasing condom use during anal sex, especially with partners whose HIV status is not known or whose viral load 
is not suppressed, remains an important public health goal.
Data Source: National HIV Behavioral Surveillance (NHBS). See Technical Notes for additional information.
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Reduce Sexual or Injection Risk Behavior among PWID by 25%
Percentage of persons who inject drugs (PWID) who report condomless sexual intercourse 















2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
Status
Baseline: 2006 DHAP Strategic Plan
Annual Target
2015 Goal
Sexual and drug injection 
risk behaviors have increased 
among people who inject 
drugs, especially young people
Sexual intercourse without a condom and use of non-sterile injection equipment both put people who inject drugs 
(PWID) at increased risk for acquiring and transmitting HIV, especially 
if other highly effective risk reduction strategies such as pre-exposure 
prophylaxis (PrEP) and viral suppression among partners with HIV are 
not used. Every three years, CDC collects data about sexual and drug 
use behaviors among PWID in selected cities. For this indicator, risky 
sexual behavior is defined as condomless vaginal or anal sex with a 
partner of the opposite sex, regardless of HIV status; risky drug use 
behavior is defined as using a syringe that had been used by someone 
else. Other strategies that are not monitored by this indicator, such as 
the use of PrEP, can also reduce the risk of HIV among PWID.
From 2006 to 2012, the percentage of PWID reporting condomless sex 
or syringe sharing in the past 12 months increased 5% from 73.1% to 
76.9%. In 2012, about 1 of 3 PWID (30%) reported sharing syringes; 70% 
reported condomless vaginal sex and 25% reported condomless anal 
sex in the past 12 months. The 2012 target (69.4%) was not met. Much 
improvement will be needed to reach the 2015 goal (54.8%).
Differences were found among subgroups. Risk behavior as 
measured by this indicator increased 28% for Hispanics/Latinos who 
inject drugs from 2006 to 2012 but remained stable for other race/
ethnicity groups. By age, condomless sex and/or syringe sharing 
increased 20% among persons aged 18-29 years who inject drugs; 
10% among those aged 30-39 years; and 7% among those aged 
40-49 years. These risks increased 9% among males who inject drugs
and 3% among females who inject drugs. In 2012, no group had met the 2015 goal (54.8%). Persons under 40
years of age who inject drugs, especially those aged 18-29 years, were furthest from the goal.
Action Needed: To achieve the 2015 goal, targeted and scaled combination HIV prevention strategies―including access to and 
use of condoms, drug treatment and access to sterile needles and syringes, pre-exposure prophylaxis, antiretroviral treatment for 
those infected, and risk-reduction counseling―are needed for people who inject drugs. Stigma related to drug use, and social and 
economic factors that affect access to HIV treatment (e.g., homelessness, incarceration, lack of insurance), must also be addressed.
















Data Source: National HIV Behavioral Surveillance (NHBS). See Technical Notes for additional information.
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Increase Linkage to HIV Medical Care to 85%
Percentage of persons with HIV who are linked to HIV medical care 
within 3 months after diagnosis

















DHAP Strategic PlanBaseline: 2009
More progress is needed linking 
people to HIV medical care. 
1 of 5 persons with HIV were not 
linked to HIV medical care within 
3 months after diagnosis in 2013.
Linking people to HIV medical care immediately after diagnosis is essential for maximizing the benefits of early 
treatment and reducing the risk of transmission to others. CDC 
monitors linkage to HIV medical care using laboratory data from 
areas with complete reporting of CD4 and viral load test results. 
The number of areas meeting this criterion increased from 13 
for 2009 to 28 for 2013. People who had a CD4 or viral load test 
within 3 months after diagnosis are considered linked to HIV 
medical care.
From 2009 to 2013, the overall trend in linkage to HIV medical 
care remained stable. Results were similar when the analysis 
was limited to areas with complete reporting for all 5 years. The 2013 target (73.0%) was met, but the low NHAS 
baseline (65%) yielded easy-to-reach targets. More improvement will be needed to reach the 2015 goal of 85.0%.
Linkage to HIV medical care remained stable across age, 
gender, race/ethnicity, and transmission risk subgroups―with 
the exception of a 10% decline among males who inject drugs 
and a 4% decline among 13-24 year olds. Since 2012, the 
2015 goal (85.0%) has been met among people aged 45 years 
and older. Young people aged 13-24 years, blacks/African 
Americans, and people who inject drugs are furthest from the 
2015 goal.
Action Needed: To achieve the 2015 goal, HIV testing 
programs need protocols and strategies for ensuring linkage 
to HIV medical care especially among young people, blacks/
African Americans, and people who inject drugs. Complete 
reporting of CD4 and viral load test results is needed from all 
areas to improve monitoring of linkage to care at the local, 
state and national level.













Data Source: National HIV Surveillance System (NHSS). See Technical Notes for additional information.
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Increase Viral Suppression among Persons in HIV Medical Care by 10%



















DHAP Strategic PlanBaseline: 2009
Viral suppression has increased 
among persons in HIV medical 
care. 4 of 5 persons in care had 
a suppressed viral load in 2013.
The ultimate goal of HIV treatment is to achieve viral suppression, meaning the amount of HIV in the body is very 
low or undetectable. This is important for people with HIV to stay healthy, live longer and reduce their chances 
of passing HIV to others. A person’s viral load is suppressed when the results of a viral load test show that HIV is 
undetectable or that there are fewer than 200 copies of HIV per 
milliliter of plasma.
From 2009 to 2013, the percentage of persons in HIV medical care 
who had achieved viral suppression increased by 12%, from 71.6% 
to 80.1%. The 2013 target (74.5%) was met and exceeded. In 2013, 
the 2015 goal for the nation (78.8%) was met.
Viral suppression improved across all subgroups from 2009 to 2013 
but the amount of improvement varied. By gender, viral suppression increased 24% among transgender persons 
in care, 16% among females, and 10% among males. Among race/ethnicity groups, there was an 18% increase 
among blacks/African Americans followed by persons of other races/ethnicities (14%), Hispanics/Latinos (9%) and 
whites (8%). The greatest increase by transmission risk was among persons who inject drugs (27%) followed by 
heterosexual females (16%), heterosexual males (14%) and gay, bisexual and other men who have sex with men 
(MSM) (9%). Improvements in viral suppression ranged from 20% among 18-29 year olds, 22% among those aged 
30-49 years, and 6% among those aged 50 years and older.
In 2013, viral suppression was highest among whites in HIV medical care (86.0%), transgender persons (84.5%), 
and those 50 years and older (83.9%); it was lowest among young people aged 18-29 years (67.5%), persons who 
inject drugs (74.1%) and blacks/African Americans (75.5%). Several groups met the 2015 goal of 78.8% in 2012 
including MSM, heterosexual males, whites, and Hispanics/Latinos.
Action Needed: There is a need to establish seamless systems to link people to care immediately after diagnosis 
and support retention in care, as well as re-engagement in care where needed, to achieve and sustain viral 
suppression. Health care providers, health departments, community-based organizations, and people living with 
HIV need to continue to work together to increase retention in HIV medical care, early and effective HIV treatment, 
and adherence to HIV treatment.
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10
Status
DHAP Strategic PlanBaseline: 2009
Annual Target
2015 Goal
Percentage of persons in HIV medical care who report condomless anal or vaginal intercourse 
during the past 12 months with a partner of discordant or unknown HIV status
Condomless sex has decreased 
among persons in HIV medical 
care. Only 10% of people in 
care reported condomless anal 
or vaginal sex in 2013.
Condomless anal or vaginal sex between a person living with HIV and an uninfected partner results in a 
substantial number of HIV infections each year in the United States. CDC encourages all people living with HIV 
to use condoms during anal and vaginal sex, including those who are taking antiretroviral treatment that reduces 
transmission risk.
From 2009 to 2013, condomless anal or vaginal sex with a discordant 
or unknown HIV status partner in the past 12 months decreased 
17% among persons in HIV medical care. In 2013, about 1 of 10 
persons in HIV medical care (10.7%) reported condomless sex. The 
2013 target (11.2%) was met. To meet the 2015 goal (8.6%), efforts to 
reduce condomless sex will need to improve at a quicker pace than 
previously achieved.
The decrease in condomless sex varied across subgroups. Among transmission risk groups, heterosexual males had 
the greatest decrease (24%) followed by heterosexual females (22%); gay, bisexual and other men who have sex 
with men (MSM) (11%); and persons who inject drugs (3%). By race/ethnicity, the greatest decrease was among 
blacks/African Americans (21%) followed by Hispanics/Latinos (17%), persons of other races/ethnicities (13%) 
and whites (11%). By age, young people aged 18-29 years had the greatest decrease (23%) followed by those 50 
years and older (13%), 40-49 year olds (11%), and 30-39 year olds (10%). Condomless sex decreased 22% among 
females and 14% among males.
In 2013, condomless sex was lowest among persons with HIV aged 50 years and older (6.7%), heterosexual men 
(7.1%), and blacks/African Americans (8.4%). It was highest among person who inject drugs (26.6%), persons under 
39 years of age (19.7% for 18-29 year olds and 18.1% for 30-39 year olds), and persons of other races/ethnicities 
(14.8%). The 2015 goal (8.6%) was met in 2012 for people aged 50 years and older and for heterosexual men. 
Persons who inject drugs were furthest from the goal.
Action Needed: To achieve the 2015 goal, individual and group-level interventions are needed to increase 
access to and use of condoms during anal or vaginal sex. Structural-level interventions―such as distributing free 
condoms in diverse venues, social marketing campaigns or policy change―can address the social, economic and 
political environments that affect condom availability and use. Access and adherence to HIV treatment and pre-
exposure prophylaxis for uninfected partners are also critically important to reduce onward HIV transmission.
Data Source: Medical Monitoring Project (MMP). See Technical Notes for additional information.
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HIV-Related Disparities and Health Inequities: 
Increase Linkage to HIV Medical Care among Specific Groups to 85% or Greater
Linkage to HIV medical 
has not improved among 
any race/ethnicity group.
People of all races/ethnicities need HIV medical care as soon as possible after receiving an HIV diagnosis to 
improve their health and reduce the risk of onward transmission of the virus. The unique needs and perspectives of 
members of specific race/ethnicity groups must be addressed to ensure that all individuals with diagnosed HIV are 
linked to HIV medical care without delay.
CDC monitors linkage to HIV medical care using laboratory data from areas 
with complete reporting of CD4 and viral load test results. The number of 
areas these data are based on doubled from 13 for 2009 to 28 for 2013. 
People who had a CD4 or viral load test within 3 months after diagnosis are 
considered linked to HIV medical care. 
From 2009 to 2013, there was no improvement in linkage to HIV medical care among blacks/African Americans, 
Hispanics/Latinos or whites. Linkage to HIV medical care improved slightly (by 6%) among persons of other races/
ethnicities during this time. In 2013, 86% of whites were linked to HIV medical care within 3 months after diagnosis 
followed by 84% of persons of other races/ethnicities, 83% of Hispanics/Latinos, and 79% of blacks/African 
Americans.
The 2013 target was met for whites and persons of other races/ethnicities. The 2015 goal has been met for whites 
since 2011. The 2013 target was not met for blacks/African Americans or Hispanics/Latinos though there was 
movement toward the target for these groups. More work will be needed to reach the 2015 goal of 85% especially 
for blacks/African Americans.
Action Needed: To achieve the 2015 goal, improved coordination and collaboration will be needed among health 
care providers, health departments, and community-based organizations to successfully link more people with HIV 
to HIV medical care. Linkage to medical care needs to happen as soon as possible after diagnosis.
Linkage to HIV Medical Care among Blacks/African Americans
• Blacks/African Americans have the lowest
percentage linked to HIV medical care
among all race/ethnicity groups.
• In 2013, 79% of blacks/African Americans
with HIV were linked to HIV medical care
within 3 months after diagnosis.
• The percentage of blacks/African Americans
linked to HIV medical care remained stable
from 2009 to 2013.
• The 2013 target (80.1%) was not met
although there was movement toward the
target from 2012 to 2013.
• More work is needed to improve linkage to





















Data Source: National HIV Surveillance System (NHSS). See Technical Notes for additional information.
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Linkage to HIV Medical Care among Hispanics/Latinos
• In 2013, more than 4 of 5 Hispanics/
Latinos (83.0%) with HIV were linked to 
HIV medical care within 3 months after 
diagnosis.
• The percentage of Hispanics/Latinos with 
HIV who were linked to HIV medical care 
remained stable from 2009 to 2013. 
• The 2013 target (83.9%) was not met 
although there was movement toward the 
target from 2012 to 2013. 
• Continued effort is needed to reach the 
2015 goal of 85.0% among Hispanics/
Latinos.



















Linkage to HIV Medical Care among 
Whites
• In 2013, more than 4 of 5 whites (86.2%) 
with HIV were linked to HIV medical care 
within 3 months after diagnosis.
• Linkage to HIV medical care was stable 
among whites from 2009 to 2013.
• The 2013 target (84.1%) was met.
• Since 2011, the 2015 goal of 85% had been 
met among whites.



















Linkage to HIV Medical Care among Persons of Other Races/Ethnicities
• In 2013, 83.6% of persons of other races/
ethnicities with HIV were linked to 
HIV medical care within 3 months after 
diagnosis.
• There was a 6% increase in linkage to HIV 
medical care from 2009 to 2013 among 
persons of other races/ethnicities, although 
the percentage declined slightly from 2011 
to 2013.
• The 2013 target (81.4%) was met. In 2013, 
the percentage linked to HIV medical care 
was 86.2% for American Indian/Alaska 
Natives, 85.3% for persons of multiple 
races, 82.4% for Asians, and 70.2% for 
Native Hawaiians/Other Pacific Islanders. [data not shown]
• In 2013, the 2015 goal of 85.0% was met among American Indian/Alaska Natives and persons of multiple  
races/ethnicities.
79.0%
















Baseline: 2009 DHAP Strategic Plan
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HIV-Related Disparities and Health Inequities: 
Increase Viral Suppression among Specific Groups by at least 20%
Viral suppression has 
improved among MSM and 
blacks/African Americans. 
No improvement was found 
among Hispanics/Latinos.
Establishing seamless systems to link people with HIV to HIV medical care immediately after diagnosis and support 
retention in care are essential for achieving viral suppression and maximizing the benefits of early treatment. This 
is especially important in communities that have the greatest burden of 
HIV.
CDC monitors viral suppression among people in HIV medical care 
(see page 15) and uses this information along with surveillance data on 
people living with an HIV diagnosis to estimate viral suppression among 
all HIV-diagnosed people. This includes those who are in HIV medical 
care and those who are not. The indicator of viral suppression estimates 
how many people with diagnosed HIV have an HIV viral load that is 
undetectable or fewer than 200 copies of HIV per milliliter of plasma.
From 2009 to 2012, the overall percentage of people with a suppressed viral load increased by 10% from 37.8% to 
41.7%. Trends in viral suppression varied across groups: improvements were seen among blacks/African Americans 
(14%) and MSM (10%). Viral suppression remained stable at 35% among Hispanics/Latinos.
The 2012 target was met for MSM and blacks/African Americans. With continued effort, the 2015 goal can be met 
for these groups. The 2012 target was not met for Hispanics/Latinos. More intensified effort will be needed to 
reach the goal for this group. As of 2012, no group had met the 2015 goal.
Action Needed: Increasing the number of people living with HIV in disproportionately affected communities 
who achieve and maintain viral suppression is essential for reducing disparities in HIV infection and mortality. 
Strategies are needed to improve linkage to HIV medical care, and retention in care, especially among Hispanics/
Latinos. Efforts to address underlying social determinants of health, such as reducing stigma associated with HIV 
and increasing access to health care and supportive services, could increase timely HIV diagnosis, retention in care, 
treatment, and viral suppression.
Viral Suppression among MSM with Diagnosed HIV
• From 2009 to 2012, viral suppression 
increased 10% among men with HIV 
infection attributed to male-to-male sexual 
contact. 
• Nearly half of MSM with HIV had a 
suppressed viral load in 2012.
















Baseline: 2009 DHAP Strategic Plan
Data Source: Medical Monitoring Project (MMP) and National HIV Surveillance System (NHSS). See Technical Notes for additional information.
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Viral Suppression among blacks/
African Americans with Diagnosed 
HIV
• From 2009 to 2012, the percentage of 
blacks/African Americans with HIV who 
had a suppressed viral load increased 14% 
from 34.1% to 39.0%.
• In 2012, more than 1 of 3 blacks/African 
Americans with HIV had a suppressed viral 
load.


















Baseline: 2009 DHAP Strategic Plan
Viral Suppression among Hispanics/
Latinos with Diagnosed HIV
• From 2009 to 2012, the percentage of 
Hispanics/Latinos with HIV who had a 
suppressed viral load remained stable at 
about 35%.
• In 2012, 35.6% of Hispanics/Latinos with 
HIV had a suppressed viral load.

















Baseline: 2009 DHAP Strategic Plan
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1 The United States refers to the 50 states and the District of Columbia. Where indicator data are available for the United States and US 
dependent areas, they are presented for the United States and US dependent areas. The Technical Notes provide the geographic specification 
for each indicator.
Technical Notes 
Increase Knowledge of HIV-Positive Status
Objective: By 2015, increase to 90% the percentage of people living with HIV who know their serostatus
Indicator: Percentage of HIV-infected persons aged 13 years and older who are aware of their HIV infection
Numerator: Estimated number of persons aged 13 years and older living with diagnosed HIV at year-end
Denominator: Estimated number of persons aged 13 years and older who were living with HIV infection in the 
United States at year-end. This includes those who had their HIV infection diagnosed as well as those whose HIV 
infection was undiagnosed.
Data Source: National HIV Surveillance System (NHSS)
Indicator Notes: HIV surveillance data for persons aged >13 years at diagnosis from the 50 states and the District 
of Columbia were used to estimate HIV prevalence (the total number of people living with HIV). An extended 
back-calculation model was used that considers the estimated annual number of HIV diagnoses, stage of disease at 
diagnosis, and the number of deaths among persons with HIV infection. The number of people living with HIV 
infection who are unaware of their infection is calculated by subtracting the number of people living with diagnosed 
HIV infection from the overall HIV prevalence estimate. This estimate is based on HIV diagnoses, not individual 
awareness of HIV status. Some people who were diagnosed with HIV may be unaware of their HIV status because 
they did not receive their test results. Differences between current and previous estimates of prevalence may be due to 
the availability of additional information, more complete data for previous years, the inclusion of additional years of 
data, or refinements in data adjustments and modeling.
Target Setting: The baseline year was established as 2006 in the National HIV/AIDS Strategy released in 2010 and 
was adopted for the DHAP Strategic Plan for 2011-2015. The updated 2006 estimate reported in 2013 (80.9%) was 
used as the baseline. The 2015 goal of 90.0% was set in NHAS. Annual targets assume an accelerating rate of change 
over time and were based on the following assumptions for the percentage of total change that was expected in a 
given year: 2011 (5% of total change); 2012 (15% of total change); 2013 (20% of total change); 2014 (30% of total 
change); 2015 (30% of total change). Based on these assumptions, the current annual targets are: 2011 (81.4%); 2012 
(82.7%); 2013 (84.5%); 2014 (87.3%).
References:
CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United 
States and 6 dependent areas—2013. HIV Surveillance Supplemental Report 2015;20(2). Published July 2015. http://
www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillancereport_vol20_no2.pdf. Accessed October 2, 
2015.
Reduce Late Stage HIV Diagnosis
Objective: By 2015, reduce by 25% the percentage of people with a diagnosis of stage-3 HIV infection (AIDS) within 
3 months after HIV diagnosis
Indicator: Percentage of persons aged 13 years and older with HIV infection diagnosed at stage-3 (AIDS) within 3 
months after initial HIV diagnosis
Numerator: Estimated number of persons aged 13 years and older with HIV diagnosed at stage-3 HIV infection 
(AIDS) within 3 months after initial HIV diagnosis in the calendar year
Denominator: Estimated number of persons aged 13 years and older with HIV infection diagnosed in the United 
States and 6 US dependent areas in the calendar year
Data Source: National HIV Surveillance System (NHSS)
Indicator Notes: In 2012, this objective and the indicator were revised to align with the new HHS core indicators, 
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to reflect a decrease in the percentage of people with a late HIV diagnosis instead of an increase in the percentage of 
people with HIV diagnosed at earlier stages of disease. Stage-3 (AIDS) within 3 months after diagnosis is based on 
CD4 data or documentation of an AIDS-defining condition. This information is reported to CDC by all 50 states, the 
District of Columbia, and 6 US dependent areas. Differences between current and previous data estimates may be due 
to the availability of additional information, more complete data for previous years, the inclusion of additional years of 
data, or refinements in data adjustments and modeling.
Target Setting: The baseline year was established as 2010 by DHAP. The updated 2010 estimate reported in 2013 
(25.2%) was used as the baseline. The revised 2015 goal (18.9%) reflects a 25% overall decrease from the baseline. 
Annual targets assume an accelerating rate of change over time and were based on the following assumptions for the 
percentage of total change that was expected in a given year: 2011 (5% of total change); 2012 (15% of total change); 
2013 (20% of total change); 2014 (30% of total change); 2015 (30% of total change). Based on these assumptions, 
and the updated 2010 estimate, the current annual targets are: 2011 (24.9%); 2012 (23.9%); 2013 (22.7%); 2014 
(20.8%).
References:
CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United 
States and 6 dependent areas—2013. HIV Surveillance Supplemental Report 2015;20(2). http://www.cdc.gov/hiv/
pdf/library/reports/surveillance/cdc-hiv-surveillancereport_vol20_no2.pdf. Published July 2015. Accessed October 2, 
2015.
Reduce Perinatal HIV Transmission
Objective: By 2015, reduce by 25% the perinatal HIV transmission rate
Indicator: Number of perinatally acquired pediatric HIV cases per 100,000 live births 
Numerator: Estimated number of infants with diagnosed perinatally acquired HIV infection who were born in the 
calendar year
Denominator: Estimated number of live births in the United States in the calendar year 
Data Source: National HIV Surveillance System (NHSS) (numerator); National Vital Statistics System (denominator)
Indicator Notes: The perinatal HIV transmission rate is estimated using data about mothers and infants with a 
diagnosis of HIV infection, regardless of their stage of disease at diagnosis. The data are from the 50 states and the 
District of Columbia. They are statistically adjusted to account for delays between birth and diagnosis date, as well 
as between diagnosis and reporting of HIV infection. This does not include adjustments for incomplete reporting. 
These data are for black/African American, Hispanic/Latino, and white mothers and infants. Live birth data reflect 
the race/ethnicity of the mother. Differences between current and previous estimates may be due to the availability of 
additional information, more complete data for previous years, the inclusion of additional years of data, or refinements 
in data adjustments and modeling.
Target Setting: The baseline year was established as 2008 by DHAP. The updated 2008 estimate reported in 2015 
(6.4 perinatal transmissions per 100,000 live births) was used as the baseline. The revised 2015 goal (4.8) reflects a 
25% overall decrease from the baseline. Annual targets assume an accelerating rate of change over time and were based 
on the following assumptions for the percentage of total change in a given year: 2011 (5% of total change); 2012 
(15% of total change); 2013 (20% of total change); 2014 (30% of total change); 2015 (30% of total change). Based 
on these assumptions, and the updated 2008 baseline estimate, the current annual targets are: 2011 (6.3); 2012 (6.1); 
2013 (5.8); 2014 (5.3).
References:
CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United 
States and 6 dependent areas—2013. HIV Surveillance Supplemental Report 2015;20(2). http://www.cdc.gov/hiv/
pdf/library/reports/surveillance/cdc-hiv-surveillancereport_vol20_no2.pdf. Published July 2015. Accessed October 2, 
2015. 
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Reduce Sexual Risk Behavior among MSM
Objective: By 2015, reduce by 25% the percentage of gay, bisexual and other men who have sex with men (MSM) 
who report condomless anal intercourse with a male sex partner of discordant or unknown HIV status during their last 
sexual encounter
Indicator: Percentage of MSM who reported condomless anal intercourse with a male sex partner of discordant or 
unknown HIV status during their last sexual encounter
Numerator: Number of MSM who reported condomless anal intercourse (defined as not using a condom or not 
using a condom the whole time during receptive or insertive anal sex) with a male partner of discordant or unknown 
HIV status during their last sexual encounter
Denominator: Number of male, eligible participants in the CDC’s National HIV Behavioral Surveillance with 
complete, valid interview data who reported having sex with another man in the past 12 months
Data Source: National HIV Behavioral Surveillance (NHBS). NHBS MSM Cycle 2—conducted in 21 US cities 
from June to December 2008. NHBS MSM Cycle 3—conducted in 20 US cities from July to December 2011. 
NHBS MSM Cycle 4—conducted in 20 US cities from July to December 2014.
Indicator Notes: Data are collected in cities with a high burden of AIDS in venues frequented by gay, bisexual, 
and other MSM. To be eligible, respondents had to be male, 18 years of age or older, live in the local area, be able to 
complete the interview in English or Spanish, and report having ever had sex with another man. Analyses were limited 
to participants who had sex with a man in the past 12 months and complete, valid interview data. Condomless sex 
with an HIV-discordant partner at last sex is a composite measure based on self-reported HIV status of the participant 
(positive, negative, or unknown), the participant’s knowledge of the HIV status of his most recent male sex partner 
(positive, negative, or unknown), and whether the participant reported engaging in anal sex without a condom during 
his most recent sexual encounter. A partner was considered to be of discordant HIV status if the participant reported 
that one member of the partnership was known to be HIV-positive and the other was known to be HIV-negative, or 
if he did not know the HIV status of at least one member of the partnership (participant or partner). Importantly, this 
indicator does not measure the use of other risk reduction strategies, including pre-exposure prophylaxis (PrEP) or 
viral suppression among HIV-positive partners. 
Target Setting: The baseline year was established as 2008 by DHAP. The 2008 result (13.7%) was used as the 
baseline. The 2015 goal (10.3%) reflects a 25% overall decrease from the baseline. Annual targets for 2011 and 2014 
(the years during the DHAP Strategic Plan for 2011-2015 in which NHBS data are collected for MSM) assume an 
accelerating rate of change over time and are based on the formula used to set annual targets for other indicators. 
Based on these assumptions, it was anticipated that 5% of the total change expected by the end of 2015 would be seen 
in the 2011 data and that 70% of the overall change would be seen in the 2014 data. Based on these assumptions, the 
current annual targets are 13.5% for 2011 and 11.3% for 2014. 
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Reduce Sexual or Injection Risk Behavior among Persons Who Inject Drugs
Objective: By 2015, reduce by 25% the percentage of persons who inject drugs who report condomless sexual 
intercourse or risky drug injection behavior during the past 12 months
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Indicator: Percentage of persons who inject drugs who reported condomless sexual intercourse or risky drug injection 
behavior in the past 12 months
Numerator: Number of eligible male and female persons who inject drugs who reported condomless sexual 
intercourse (defined as vaginal or anal sex without a condom with a partner of the opposite sex regardless of HIV 
status) or risky drug injection behavior (defined here as using a syringe that had been used by someone else) in the past 
12 months
Denominator: Number of eligible male and female participants in the CDC’s National HIV Behavioral Surveillance 
with complete, valid interview data who reported injecting drugs in the past 12 months and who did not report a 
previous HIV-positive test result
Data Source: National HIV Behavioral Surveillance (NHBS). NHBS Injection Drug Use (IDU) Cycle 1—conducted 
in 23 US cities from May 2005 to February 2006. NHBS IDU Cycle 2—conducted in 21 US cities from June to 
December 2009. NHBS IDU Cycle 3—conducted in 20 US cities from June to December 2012.
Indicator Notes: Data are collected in cities with a high burden of AIDS. Data are collected using respondent driven 
sampling (RDS), a method in which potential respondents are recruited by their peers. Males and females were eligible 
to participate if they were 18 years of age or older, lived in the local area, could complete the interview in English or 
Spanish, and reported injecting drugs in the past 12 months. Analyses were limited to participants with complete, 
valid data who did not report a previous HIV-positive test result. Condomless sexual intercourse was defined as vaginal 
or anal sex without a condom with a partner of the opposite sex, regardless of HIV status, during the past 12 months. 
Risky drug injection behavior was defined for this indicator as using a syringe that had been used by someone else. 
Indicator analysis was conducted using RDSAT to adjust for RDS. Importantly, this indicator does not measure the 
use of other risk reduction strategies, including pre-exposure prophylaxis (PrEP) or viral suppression among HIV-
positive partners.
Target Setting: The baseline year was established as 2006 by DHAP. At the time the 2015 goal was established, this 
was the most recent year of data available prior to implementation of the DHAP Strategic Plan for 2011-2015. The 
2006 estimate of 73.1% was used as the baseline. The 2015 goal (54.8%) reflects a 25% overall decrease from the 
baseline. The annual target for 2012 (the year during the DHAP Strategic Plan for 2011-2015 for which NHBS data 
are collected for IDUs) assumes an accelerating rate of change over time and is based on the formula used to set annual 
targets for other indicators. It was anticipated that 20% of the total expected change would be seen in the 2012 data. 
Based on this assumption, the annual target for 2012 is 69.4%. 
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Increase Linkage to HIV Medical Care
Objective: By 2015, increase to 85% the percentage of persons with HIV who are linked to HIV medical care within 
3 months after diagnosis
Indicator: Percentage of HIV-diagnosed persons who are linked to HIV medical care as evidenced by having had a 
CD4 count or HIV viral load measure within 3 months after diagnosis
Numerator: Estimated number of persons aged 13 years and older with HIV diagnosed in the calendar year with a 
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CD4 count or HIV viral load measure within 3 months after diagnosis in jurisdictions that reported all CD4 and HIV 
viral load test results to CDC
Denominator: Estimated number of persons aged 13 years and older with HIV diagnosed in the calendar year 
(regardless of stage of disease at diagnosis) in jurisdictions that reported all CD4 and HIV viral load test results to 
CDC 
Data Source: National HIV Surveillance System (NHSS)
Indicator Notes: Linkage to HIV medical care was based on data for persons with HIV infection diagnosed in the 
jurisdictions that reported all CD4 and HIV viral load test results to CDC. This included, in 2009, 13 jurisdictions—
California (San Francisco only); Delaware; Indiana; Iowa; Kentucky; Missouri; Nebraska; New York (excluding New 
York City); North Dakota; South Carolina; West Virginia; Wyoming; and the District of Columbia; in 2010, 14 
jurisdictions—all reporting in 2009 (except Kentucky) plus Illinois and Minnesota; in 2011, 19 jurisdictions—all 
reporting in 2010 plus Georgia, Hawaii, Louisiana, Michigan, New Hampshire, New York (including New York City), 
and California (including only San Francisco and Los Angeles County); in 2012, 18 jurisdictions—California, District 
of Columbia, Hawaii, Illinois, Indiana, Iowa, Louisiana, Maryland, Michigan, Missouri, New Hampshire, New York, 
North Dakota, South Carolina, Texas, Utah, West Virginia, and Wyoming; and in 2013, 28 jurisdictions—Alabama, 
Alaska, Arkansas, California, District of Columbia, Hawaii, Illinois, Indiana, Iowa, Louisiana, Maine, Maryland, 
Michigan, Missouri, Nebraska, New Hampshire, New York (including New York City), North Dakota, Oregon, South 
Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, and Wisconsin.
These data represent the best national estimate of linkage to care that is currently available. The representativeness of 
these data will improve over time as the number of jurisdictions reporting complete CD4 and HIV viral load data to 
CDC increases. People were considered linked to HIV medical care if laboratory data were reported showing that they 
had at least 1 CD4 or viral load test performed within 3 months after initial HIV diagnosis. Results for this indicator 
can be affected by changes in linkage to care, the number of areas reporting data, and completeness of laboratory 
reporting. 
Target Setting: The National HIV/AIDS Strategy released in 2010 established the baseline at 65.0% for the year 
2006. It also set the 2015 goal at 85.0%. This baseline and goal were adopted for the DHAP Strategic Plan for 2011-
2015. Annual targets assume an accelerating rate of change over time and were based on the following assumptions for 
the percentage of total change that was expected to be achieved in a given year: 2011 (5% of total change); 2012 (15% 
of total change); 2013 (20% of total change); 2014 (30% of total change); 2015 (30% of total change). Based on these 
assumptions, the current annual targets are: 2011 (66.0%); 2012 (69.0%); 2013 (73.0%); 2014 (79.0%). 
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Increase Viral Suppression among Persons in HIV Medical Care
Objective: By 2015, increase by 10% the percentage of persons in HIV medical care with a suppressed viral load
Indicator: Percentage of adults in HIV medical care whose most recent HIV viral load test in the past 12 months 
showed that HIV viral load was suppressed
Numerator: Estimated number of adults aged 18 years and older in HIV medical care whose most recent viral load 
test in the past 12 months showed that HIV viral load was suppressed (defined as undetectable or fewer than 200 
copies of HIV per milliliter of plasma) 
Denominator: Estimated number of adults aged 18 years and older in HIV medical care in the United States and 
Puerto Rico in the first four months of the calendar year 
Data Source: Medical Monitoring Project (MMP) 
Indicator Notes: Data from MMP are based on a three-stage sampling approach that is designed to produce 
nationally representative information about adults receiving HIV medical care in the United States and Puerto Rico. 
Data are collected for samples of patients at outpatient HIV medical care facilities. Since 2009, 23 jurisdictions have 
been funded to participate in MMP activities. These jurisdictions include 16 states (California, Delaware, Florida, 
Georgia, Illinois, Indiana, Michigan, Mississippi, New Jersey, New York, North Carolina, Oregon, Pennsylvania, Texas, 
Virginia, and Washington); 6 cities/counties (Chicago, Illinois; Houston, Texas; Los Angeles County, California; New 
York City, New York; Philadelphia, Pennsylvania; and San Francisco, California); and Puerto Rico. To be included, 
patients must be at least 18 years old, diagnosed with HIV, and have received HIV medical care at least once from 
January to April of the calendar year. Trained staff collect data through face-to-face interviews and medical record 
abstraction. These data are weighted to produce national estimates.
The data used for this indicator are based on medical records. Viral suppression is defined as having a most recent HIV 
viral load test result in the past 12 months that was undetectable or fewer than 200 copies/mL of plasma. 
Target Setting: The baseline year was established as 2009 in the DHAP Strategic Plan for 2011-2015. The 2009 
estimate (71.6%) was used as the baseline. The 2015 goal (78.8%) reflects a 10% overall increase from the baseline. 
Annual targets assume an accelerating rate of change over time, and were based on the following assumptions for the 
percentage of total change that was expected to be achieved in a given year: 2011 (5% of total change); 2012 (15% of 
total change); 2013 (20% of total change); 2014 (30% of total change); 2015 (30% of total change). Based on these 
assumptions, the current annual targets are: 2011 (72.0%); 2012 (73.0%); 2013 (74.5%); 2014 (76.6%).
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Reduce Sexual Risk Behavior among Persons in HIV Medical Care
Objective: By 2015, reduce by 33% the percentage of persons in HIV medical care who report condomless anal or 
vaginal intercourse during the past 12 months with a partner of discordant or unknown HIV status
Indicator: Percentage of adults in HIV medical care who report condomless anal or vaginal intercourse in the past 12 
months with a partner of discordant or unknown HIV status
Numerator: Estimated number of adults aged 18 years and older in HIV medical care who report condomless anal or 
vaginal intercourse in the last 12 months with a partner of discordant or unknown HIV status
Denominator: Estimated number of adults aged 18 years and older in HIV medical care in the first four months of 
the calendar year in the United States and Puerto Rico 
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Data Source: Medical Monitoring Project (MMP) 
Indicator Notes: Data from MMP are based on a three-stage-sampling approach that is designed to produce 
nationally representative information about adults receiving HIV medical care in the United States and Puerto Rico. 
Data are collected for samples of patients at outpatient HIV medical care facilities. Since 2009, 23 jurisdictions have 
been funded to participate in MMP activities. These jurisdictions include 16 states (California, Delaware, Florida, 
Georgia, Illinois, Indiana, Michigan, Mississippi, New Jersey, New York, North Carolina, Oregon, Pennsylvania, Texas, 
Virginia, and Washington); 6 cities/counties (Chicago, Illinois; Houston, Texas; Los Angeles County, California; New 
York City, New York; Philadelphia, Pennsylvania; and San Francisco, California); and Puerto Rico. To be included, 
patients must be at least 18 years old, diagnosed with HIV, and have received HIV medical care at least once from 
January to April of the calendar year. Trained staff collect data through face-to-face interviews and medical record 
abstraction. These data are weighted to produce national estimates. 
This indicator is based on self-reported data from the face-to-face interviews. A discordant partner was a sex partner 
that the interview participant reported as being HIV negative. Partners of unknown HIV status include those who 
did not know their HIV status or did not disclose their status to the interview participant. This indicator measures 
condomless sex (insertive anal sex, receptive anal sex or vaginal sex without a condom) and does not take HIV 
treatment, viral load, partners’ use of PrEP or other factors that affect HIV transmission into account. 
Target Setting: The baseline year was established as 2009 in the DHAP Strategic Plan for 2011-2015. The 2009 
estimate (12.9%) was used as the baseline. The 2015 goal (8.6%) reflects a 33% overall decrease from the baseline. 
Annual targets for 2011 through 2014 assumed an accelerated rate of change over time and were based on the 
following assumptions for the percentage of total change that was expected to be achieved in a given year: 2011 (5% 
of total change); 2012 (15% of total change); 2013 (20% of total change); 2014 (30% of total change); 2015 (30% 
of total change). Based on these assumptions, the current annual targets are: 2011 (12.7%); 2012 (12.1%); 2013 
(11.2%); 2014 (9.9%). 
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Reduce HIV-Related Disparities and Health Inequities: Linkage to HIV Medical Care
Objective: By 2015, increase to 85% or greater for all race/ethnicity groups the percentage of persons diagnosed with 
HIV who are linked to HIV medical care within 3 months after diagnosis 
Indicator: Percentage of blacks/African Americans, Hispanics/Latinos, whites, and persons of other races/ethnicities 
with HIV who are linked to HIV medical care as evidenced by having had a CD4 count or HIV viral load measure 
within 3 months after diagnosis
Numerator: Estimated number of blacks/African Americans, Hispanics/Latinos, whites, and persons of other races/
ethnicities aged 13 years and older with HIV diagnosed in the calendar year and who have been linked to HIV 
medical care (as evidenced by having had a CD4 count or viral load measure within 3 months after diagnosis) in 
jurisdictions that reported all CD4 and viral load test results to CDC
Denominator: Estimated number of blacks/African Americans, Hispanics/Latinos, whites, and persons of other races/
ethnicities aged 13 years and older with HIV diagnosed in the calendar year (regardless of stage of disease at diagnosis) 
in jurisdictions that reported all CD4 and viral load test results to CDC
Data Source: National HIV Surveillance System (NHSS)
Indicator Notes: Linkage to HIV medical care was based on data for blacks/African Americans, Hispanics/Latinos, 
whites, and persons of other races/ethnicities with HIV infection diagnosed in the jurisdictions that reported all 
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CD4 and viral load test results to CDC. This included, in 2009, 13 jurisdictions—California (San Francisco only); 
Delaware; Indiana; Iowa; Kentucky; Missouri; Nebraska; New York (excluding New York City); North Dakota; South 
Carolina; West Virginia; Wyoming; and the District of Columbia; in 2010, 14 jurisdictions—all reporting in 2009 
(except Kentucky) plus Illinois and Minnesota; in 2011, 19 jurisdictions—all reporting in 2010 plus Georgia, Hawaii, 
Louisiana, Michigan, New Hampshire, New York (including New York City), and California (including only San 
Francisco and Los Angeles County); in 2012, 18 jurisdictions—California, District of Columbia, Hawaii, Illinois, 
Indiana, Iowa, Louisiana, Maryland, Michigan, Missouri, New Hampshire, New York, North Dakota, South Carolina, 
Texas, Utah, West Virginia, and Wyoming; and in 2013, 28 jurisdictions—Alabama, Alaska, Arkansas, California, 
District of Columbia, Hawaii, Illinois, Indiana, Iowa, Louisiana, Maine, Maryland, Michigan, Missouri, Nebraska, 
New Hampshire, New York (including New York City), North Dakota, Oregon, South Carolina, South Dakota, 
Tennessee, Texas, Utah, Virginia, Washington, West Virginia, and Wisconsin.
These data represent the best national estimates of linkage to HIV medical care that are currently available. People 
were considered linked to HIV medical care if laboratory data were reported showing that they had at least 1 CD4 or 
VL test performed within 3 months after initial HIV diagnosis. Results for this indicator can be affected by changes in 
linkage to care, the number of areas reporting data, and completeness of laboratory reporting. 
Target Setting: The baseline year was established as 2010 by DHAP. The 2015 goal was set by DHAP before data 
were available at 75.0% or greater for all race/ethnicity groups. The 2015 goal has been re-set to 85% or greater in all 
race/ethnicity groups. This aligns with the 2015 goal established in the National HIV/AIDS Strategy released in 2010 
and the DHAP Strategic Plan for 2011-2015 for the nation as a whole. Annual targets assume an accelerating rate of 
change over time and were based on the following assumptions for the percentage of total change that was expected 
to be achieved in a given year: 2011 (5% of total change); 2012 (15% of total change); 2013 (20% of total change); 
2014 (30% of total change); 2015 (30% of total change). Based on these assumptions, the annual targets for blacks/
African Americans are: 2011 (77.3%); 2012 (78.5%); 2013 (80.1%); 2014 (82.6%). The annual targets for Hispanics/
Latinos are: 2011 (83.2%); 2012 (83.5%); 2013 (83.9%); 2014 (84.4%). The annual targets for whites are: 2011 
(83.6%); 2012 (83.8%); 2013 (84.1%); 2014 (84.6%). The annual targets for persons of other races/ethnicities are: 
2011 (79.3%); 2012 (80.2%); 2013 (81.4%); 2014 (83.2%). 
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Reduce HIV-Related Disparities and Health Inequities: Viral Suppression among Persons 
with Diagnosed HIV
Objective: By 2015, increase by at least 20% the percentage of men who have sex with men (MSM), blacks/African 
Americans, and Hispanics/Latinos with a suppressed viral load
Indicator: Percentage of HIV-diagnosed MSM, blacks/African Americans, or Hispanics/Latinos aged 18 years and 
older whose most recent HIV viral load test in the past 12 months showed that HIV was suppressed 
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Numerator: Estimated number of adult MSM, blacks/African Americans, or Hispanics/Latinos aged 18 years and 
older in HIV medical care whose most recent viral load test in the past 12 months showed that HIV was suppressed 
(defined as undetectable or fewer than 200 copies of HIV per milliliter of plasma) 
Denominator: Estimated number of adult MSM, blacks/African Americans, or Hispanics/Latinos aged 18 years and 
older in the United States and Puerto Rico who were diagnosed with HIV prior to the start of the reporting year and 
were alive at the end of the reporting year 
Data Source: Medical Monitoring Project (MMP); National HIV Surveillance System (NHSS) 
Indicator Notes: This indicator measures viral suppression using MMP data on HIV viral suppression from adults 
receiving HIV medical care and NHSS data on all people living with an HIV diagnosis. MMP data were used to 
estimate the number of adult MSM, blacks/African Americans, and Hispanics/Latinos receiving HIV medical care in 
the United States and Puerto Rico who achieved viral suppression. These data are based on medical records of HIV-
diagnosed persons who received HIV medical care at least once from January to April of the calendar year. HIV viral 
suppression was assessed using information about the most recent HIV viral load test. Suppressed HIV viral load was 
defined as a result that was undetectable or fewer than 200 copies/mL. NHSS data were used to estimate the number 
of MSM, blacks/African Americans, and Hispanics/Latinos who had been diagnosed with HIV in the United States or 
Puerto Rico and were alive at the end of the calendar year. 
Target Setting: Data from 2009 were used by DHAP to establish the baseline. The baseline number for each group 
was: 41.5% for MSM; 34.1% for blacks/African Americans; and 35.4% for Hispanics/Latinos. The 2015 goals (49.8% 
for MSM; 40.9% for blacks/African Americans; 42.5% for Hispanics/Latinos) reflect the 20% increase that was called 
for in the National HIV/AIDS Strategy released in 2010 and the DHAP Strategic Plan for 2011-2015. Annual targets 
assume an accelerating rate of change over time, and were based on the following assumptions for the percentage of 
total change that was expected to be achieved in a given year: 2011 (5% of total change); 2012 (15% of total change); 
2013 (20% of total change); 2014 (30% of total change); 2015 (30% of total change). Based on these assumptions, 
the annual targets for MSM with diagnosed HIV are: 2011 (41.9%); 2012 (43.2%); 2013 (44.8%); 2014 (47.3%). 
The annual targets for blacks/African Americans with diagnosed HIV are: 2011 (34.4%); 2012 (35.5%); 2013 
(36.8%); 2014 (38.9%). The annual targets for Hispanics/Latinos with diagnosed HIV are: 2011 (35.8%); 2012 
(36.8%); 2013 (38.2%); 2014 (40.4%). 
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